PPY and obesity disorder: In addition to GLP-1, pancreatic polypeptide (PP) and peptide YY (PYY)—peptides of gut origin affecting the gastrointestinal tract—have central anorexigenic effects (gut-brain peptides) and have been evaluated as possible treatments for obesity.